<?xml version="1.0" encoding="UTF-8"?>
<article-meta class="article-meta">
 <article-id pub-id-type="pmcid" class="article-id">5921405</article-id>
 <article-id pub-id-type="publisher-id" class="article-id">RPS-13-250</article-id>
 <article-id pub-id-type="doi" class="article-id">10.4103/1735-5362.228955</article-id>
 <article-categories class="article-categories">
  <div subj-group-type="heading" class="subj-group" xmlns="http://www.w3.org/1999/xhtml">
   <span class="subject">Original Article</span>
  </div>
 </article-categories>
 <title-group class="title-group">
  <div class="article-title" xmlns="http://www.w3.org/1999/xhtml">Development, physicochemical characterization, and antimicrobial evaluation of niosomal myrtle essential oil</div>
 </title-group>
 <div class="contrib-group" xmlns="http://www.w3.org/1999/xhtml">
  <contrib contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Raeiszadeh</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Mahboobeh</span>
   </name>
   <a ref-type="aff" rid="aff1" href="#aff1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <a ref-type="aff" rid="aff2" href="#aff2" xmlns="http://www.w3.org/1999/xhtml">2</a>
  </contrib>
  <contrib contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Pardakhty</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Abbas</span>
   </name>
   <a ref-type="aff" rid="aff3" href="#aff3" xmlns="http://www.w3.org/1999/xhtml">3</a>
  </contrib>
  <contrib contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Sharififar</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Fariba</span>
   </name>
   <a ref-type="aff" rid="aff1" href="#aff1" xmlns="http://www.w3.org/1999/xhtml">1</a>
  </contrib>
  <contrib contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Farsinejad</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Alireza</span>
   </name>
   <a ref-type="aff" rid="aff4" href="#aff4" xmlns="http://www.w3.org/1999/xhtml">4</a>
  </contrib>
  <contrib contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Mehrabani</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Mehrnaz</span>
   </name>
   <a ref-type="aff" rid="aff5" href="#aff5" xmlns="http://www.w3.org/1999/xhtml">5</a>
  </contrib>
  <contrib contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Hosseini-nave</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Hossein</span>
   </name>
   <a ref-type="aff" rid="aff6" href="#aff6" xmlns="http://www.w3.org/1999/xhtml">6</a>
  </contrib>
  <contrib contrib-type="author" class="contrib" xmlns="">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Mehrabani</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">Mitra</span>
   </name>
   <a ref-type="aff" rid="aff1" href="#aff1" xmlns="http://www.w3.org/1999/xhtml">1</a>
   <a ref-type="corresp" rid="cor1" href="#cor1" xmlns="http://www.w3.org/1999/xhtml">*</a>
  </contrib>
 </div>
 <aff id="aff1" class="aff">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">1</span>
  <span class="italic" xmlns="http://www.w3.org/1999/xhtml">Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, I.R. Iran</span>
 </aff>
 <aff id="aff2" class="aff">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">2</span>
  <span class="italic" xmlns="http://www.w3.org/1999/xhtml">Department of Traditional pharmacy, School of Persian Medicine, Kerman University of Medical Sciences, Kerman, I.R. Iran</span>
 </aff>
 <aff id="aff3" class="aff">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">3</span>
  <span class="italic" xmlns="http://www.w3.org/1999/xhtml">Pharmaceutics Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, I.R. Iran</span>
 </aff>
 <aff id="aff4" class="aff">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">4</span>
  <span class="italic" xmlns="http://www.w3.org/1999/xhtml">Hematology and Laboratory Sciences Department, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, I.R. Iran</span>
 </aff>
 <aff id="aff5" class="aff">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">5</span>
  <span class="italic" xmlns="http://www.w3.org/1999/xhtml">Physiology Research Center, Neuropharmacology Institute, Kerman University of Medical Sciences, Kerman, I.R. Iran</span>
 </aff>
 <aff id="aff6" class="aff">
  <span class="label" xmlns="http://www.w3.org/1999/xhtml">6</span>
  <span class="italic" xmlns="http://www.w3.org/1999/xhtml">Department of Microbiology and Virology, School of Medicine, Kerman University of Medical Sciences, Kerman, I.R. Iran</span>
 </aff>
 <div class="author-notes" xmlns="http://www.w3.org/1999/xhtml">
  <div id="cor1" class="corresp">
   <span class="label">*</span>Corresponding author: M. Mehrabani Tel: +98-3431325019, Fax: +98-34-31325019 Email: 
   <span xlink:href="Mehrabani.mitra@gmail.com" class="email" xmlns:xlink="http://www.w3.org/1999/xlink">Mehrabani.mitra@gmail.com</span>
  </div>
 </div>
 <pub-date pub-type="ppub" class="pub-date">
  <span class="month" xmlns="http://www.w3.org/1999/xhtml">6</span>
  <span class="year" xmlns="http://www.w3.org/1999/xhtml">2018</span>
 </pub-date>
 <span class="volume" xmlns="http://www.w3.org/1999/xhtml">13</span>
 <span class="issue" xmlns="http://www.w3.org/1999/xhtml">3</span>
 <span class="fpage" xmlns="http://www.w3.org/1999/xhtml">250</span>
 <span class="lpage" xmlns="http://www.w3.org/1999/xhtml">261</span>
 <history class="history">
  <date date-type="received" class="date">
   <span class="month" xmlns="http://www.w3.org/1999/xhtml">9</span>
   <span class="year" xmlns="http://www.w3.org/1999/xhtml">2017</span>
  </date>
  <date date-type="accepted" class="date">
   <span class="month" xmlns="http://www.w3.org/1999/xhtml">1</span>
   <span class="year" xmlns="http://www.w3.org/1999/xhtml">2018</span>
  </date>
 </history>
 <div class="permissions" xmlns="http://www.w3.org/1999/xhtml">
  <span class="copyright-statement">Copyright: © 2018 Research in Pharmaceutical Sciences</span>
  <span class="copyright-year">2018</span>
  <div license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0" class="license" xmlns:xlink="http://www.w3.org/1999/xlink">
   <div class="license-p">This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</div>
  </div>
 </div>
 <div class="abstract" xmlns="http://www.w3.org/1999/xhtml">
  <p>
   <span class="italic">Myrtus communis</span> (myrtle) is well known for its therapeutic effects pertaining to the major secondary metabolites including essential oils (EOs). EOs are composed of volatile compounds and simply evaporate or decompose leading to their instability. Preparation of EOs niosomal formulation may be a promising approach to deal with these obstacles. Niosomal formulations of myrtle essential oil (nMEO) were provided using non-ionic surfactants and cholesterol (Chol). In the next steps, vesicle size, zeta potential, percentage of entrapment efficiency (EE%) and physical stability of nMEO were investigated. Finally, the effect of myrtle essential oil (MEO) and nMEO on microbial growth inhibition were assessed. Values for nMEO size and zeta potential ranged from 6.17 ± 0.32 to 7.24 ± 0.61 (μm) and -20.41 ± 0.17 to -31.75 ± 0.45 (mV), respectively. Higher degrees of EE% were obtained by F6 formulation (Span/Tween 60:Chol (50:50 molar ratio)). Moreover, niosomes have been reported to be stable at 4 °C during a three-month time period. It was revealed that nMEO F6 formulation inhibited growth of 
   <span class="italic">Staphylococcus aureus, Staphylococcus epidermidis</span>, 
   <span class="italic">Serratia marcescens</span>, and 
   <span class="italic">Bacillus subtilis</span> at concentrations lower than that of MEO. Overall, it was found that stable multilamellar vesicles were formed in the presence of 0.5% MEO and F6 formulation. This formulation also exhibited better antibacterial activity than MEO.
  </p>
 </div>
 <div class="kwd-group" xmlns="http://www.w3.org/1999/xhtml">
  <div class="title">Keywords</div>
  <span class="kwd">Antibacterial activity</span>
  <span class="kwd">Essential oil</span>
  <span class="kwd">Myrtle, 
   <span class="italic">Myrtus communis</span>
  </span>
  <span class="kwd">Niosome</span>
 </div>
</article-meta>
